AI in Healthcare: A 50-Point Trust Divide Splits Users from Skeptics

CHICAGO and VANCOUVER, BC – February 26, 2026 – A significant and widening gap in public trust threatens to slow the integration of artificial intelligence into American healthcare, according to a new study. While overall confidence in healthcare AI has fallen, a stark 50-percentage-point divide separates the small group of Americans who have used the technology from the vast majority who have not, revealing that firsthand experience is a powerful, yet limited, antidote to widespread skepticism.

The new report from research firms Reach3 Insights and Rival Technologies found that just 44% of Americans trust AI in healthcare, a notable decline from 52% in 2024. The findings, part of the ongoing 2026 Digital Health Trends study, paint a picture of a nation deeply divided. While a staggering 88% of current users express trust in the technology, that number plummets to just 38% among non-users. With 53% of the general population reporting negative feelings about AI's integration into their medical care, the data underscores a critical challenge for innovators and providers alike.

The Experience Chasm: A Tale of Two Perceptions

The core of the issue lies in a chasm of experience. Only 14% of Americans surveyed reported currently using AI for their health or wellness. Within this small cohort of early adopters, sentiment is overwhelmingly positive, with 87% feeling good about AI's role in the healthcare system. This group is leveraging AI tools primarily for informational and administrative support—tasks that carry a lower perceived risk.

Common uses cited by current users include asking health questions, getting help translating complex medical terminology, and assessing whether symptoms are serious enough to warrant a doctor's visit. This comfort with AI as an informational aid stands in stark contrast to its use in direct medical decision-making, where apprehension remains high across the board.

"What stands out in this wave is the size of the trust gap between people who have firsthand experience with AI in healthcare and those who do not," said Christine Nguyen, vice president at Reach3 Insights, in the press release. "Familiarity plays a meaningful role in shaping confidence."

This suggests a classic chicken-and-egg problem for the industry: widespread trust may require widespread adoption, but adoption is being stifled by a fundamental lack of trust. The challenge is not just technological but deeply human.

Widespread Skepticism and Lingering Fears

For the 86% of Americans not actively using health AI, the landscape looks vastly different. A significant 38% of respondents stated they are not interested in using AI for health in the future, while another 33% remain unsure. This large bloc of uncertainty and disinterest highlights a profound value and trust gap that technology alone cannot bridge.

These findings align with broader industry trends. A 2024 survey from Deloitte noted a rise in consumer distrust of generative AI for health information, while other research has consistently shown the public is more concerned than excited about AI's growing influence. The primary fears fueling this skepticism are consistent and deeply rooted: the accuracy of AI-driven information, the privacy and security of sensitive health data, and the potential erosion of human-centered care.

Patients worry that an over-reliance on algorithms could lead to misdiagnoses or impersonal, one-size-fits-all treatment that ignores individual nuance. The desire for transparency is a recurring theme. Research published in the JAMA Network Open found that a majority of patients (62.7%) want to be explicitly notified if AI is being used in their care, a demand that reflects a need for agency and understanding in a rapidly changing medical environment.

Navigating the Path to Trust

Experts argue that closing the trust gap will require a strategic shift away from simply rolling out new features and toward a more deliberate, human-centric approach. The focus must be on building confidence through transparency, education, and demonstrating tangible value in a safe environment.

"The pace of AI innovation in healthcare is accelerating, but consumer confidence develops over time," noted Matt Kleinschmit, CEO and Founder of Reach3 Insights. "Trust grows through transparency, education and thoughtful implementation. Bridging the gap between technological advancement and consumer comfort requires sustained dialogue and usage that builds credibility, not just new features."

This path forward involves several key strategies. First, healthcare organizations can build a foundation of trust by introducing AI in areas where consumers are already comfortable, such as automating administrative tasks, scheduling appointments, and providing clear, accessible health information. By proving its reliability in these lower-stakes applications, the technology can earn the credibility needed for wider acceptance in more clinical roles, such as analyzing medical images or helping to formulate treatment plans.

Furthermore, involving clinicians as key communicators is critical. Patients consistently report high levels of trust in their doctors, and leveraging that relationship to explain how AI tools are being used—as assistants to, not replacements for, human experts—can demystify the technology and alleviate fears. Ensuring robust data security and adhering to clear ethical guidelines and regulatory standards will also be non-negotiable in winning over a skeptical public. Organizations that successfully weave these elements of trust and transparency into their AI strategy will not only navigate the current skepticism but will likely define the future of an AI-enabled health industry.